FindTrial
Sign In

Application of Kailash Jeevan cream externally and internally in Burning feet

Evaluation of Kailas Jeevan lepa in the Management of Diabetic Peripheral neuropathy w.s.r to Burning feet – A Randomized Double Blinded Clinical Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033022
Enrollment
30
Registered
2021-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E136- Other specified diabetes mellituswith other specified complications

Interventions

Intervention1: Double group randomized clinical trial with Pre-test and post-test design : Two Groups Group A - Externally application thrice a day for 15 days Group B - Externally application thric

Sponsors

Dr Vedas Kolatkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with or without type 2 DM Patients on Anti-diabetic medications will be included. Patients of irrespective of sex, religion and socioeconomic status age between 25 -70 years.

Exclusion criteria

Exclusion criteria: Patients with wounds or ulcers. Pregnant and lactating women. Patients with other complications of DM such as Nephropathy, Retinopathy and Vasculopathy. Patients with other metabolic and endocrinal disorders. Patients with other causes of Neuropathy.

Design outcomes

Primary

MeasureTime frame
After the completion of the study, daha(burning feet) will be reduced in the patients. Timepoint: 4weeks—

Secondary

MeasureTime frame
it will improve the Quality of Life of the patient.Timepoint: 4weeks—

Countries

India

Contacts

Public ContactDr Keertan M S

KAHER Shri B M Kankanwadi Ayurveda Mahavidyalaya

keertanms.kaher@kleayurworld.edu.in9886238888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026